Exploring successful models of innovation— in and out of traditional biomedical research organizations—will be the focus of a three-day conference hosted by The Mount Sinai Medical Center.
The conference, SINAInnovations, to be held Monday through Wednesday, November 12-14, will feature prominent speakers from academia, the biotechnology and pharmaceutical industries, the investment community, and global media. It will highlight the most effective ways for academic medical centers to accelerate drug discovery and commercialize emerging biotechnologies, with the ultimate goal of creating better diagnostics and treatments that cure human diseases.
Keynote speakers at SINAInnovations will include: David Zaslav, President and Chief Executive Officer of Discovery Communications, and Ivan Seidenberg, Retired Chairman and CEO of Verizon Communications. There will be presentations by renowned faculty members and thought leaders from Mount Sinai School of Medicine; Johns Hopkins University; Massachusetts Institute of Technology; University of California, San Francisco; Stanford University School of Medicine; and Harvard Medical School.
As a medical school that is fully integrated with a hospital, Mount Sinai has ideal conditions for collaboration among scientists and physicians, according to Scott L. Friedman, MD, Mount Sinai’s Dean for Therapeutic Discovery, the Fishberg Professor of Medicine, and Chief of the Division of Liver Diseases. He says, “Mount Sinai has a long history of translating clinical observations and scientific discoveries into better treatments for patients. We are committed to redefining how academic medical centers contribute to innovations.”